Paper34733320
Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
Sun R and 5 others. Front Genet, 2021. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme. Papers, record 34733320. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34733320
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of a 3 RNA Binding Protein Signature for Predicting Prognosis and Treatment Response for Glioblastoma Multiforme.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28031556 | Advances in the molecular genetics of gliomas - implications for classification and therapy. | Nat Rev Clin Oncol | 2017 | https://conductscience.org/library/papers/28031556 | PubMed |
| 2 | 21586613 | Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. | Cancer Res | 2011 | https://conductscience.org/library/papers/21586613 | PubMed |
| 3 | 34326892 | Identification of the Hub Genes in Alzheimer's Disease. | Comput Math Methods Med | 2021 | https://conductscience.org/library/papers/34326892 | PubMed |
| 4 | 29339797 | A brave new world of RNA-binding proteins. | Nat Rev Mol Cell Biol | 2018 | https://conductscience.org/library/papers/29339797 | PubMed |
| 5 | 28718405 | RNA-Binding Proteins in Cancer: Old Players and New Actors. | Trends Cancer | 2017 | https://conductscience.org/library/papers/28718405 | PubMed |
| 6 | 33235359 | RNA-binding proteins in human genetic disease. | Nat Rev Genet | 2021 | https://conductscience.org/library/papers/33235359 | PubMed |
| 7 | 24659184 | Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma. | J Pathol | 2014 | https://conductscience.org/library/papers/24659184 | PubMed |
| 8 | 28521700 | Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review. | Curr Med Chem | 2017 | https://conductscience.org/library/papers/28521700 | PubMed |
| 9 | 16949250 | Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. | Genomics | 2006 | https://conductscience.org/library/papers/16949250 | PubMed |
| 10 | 11280780 | HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs. | Cancer Res | 2001 | https://conductscience.org/library/papers/11280780 | PubMed |
| 11 | 26217012 | Bicc1 Polymerization Regulates the Localization and Silencing of Bound mRNA. | Mol Cell Biol | 2015 | https://conductscience.org/library/papers/26217012 | PubMed |
| 12 | 29023197 | Mutational landscape of RNA-binding proteins in human cancers. | RNA Biol | 2018 | https://conductscience.org/library/papers/29023197 | PubMed |
| 13 | 26274615 | GNL3L Is a Nucleo-Cytoplasmic Shuttling Protein: Role in Cell Cycle Regulation. | PLoS One | 2015 | https://conductscience.org/library/papers/26274615 | PubMed |
| 14 | 29298429 | Comprehensive Genomic Characterization of RNA-Binding Proteins across Human Cancers. | Cell Rep | 2018 | https://conductscience.org/library/papers/29298429 | PubMed |
| 15 | 22455463 | clusterProfiler: an R package for comparing biological themes among gene clusters. | OMICS | 2012 | https://conductscience.org/library/papers/22455463 | PubMed |
| 16 | 30119081 | Bevacizumab and Glioblastoma: Past, Present, and Future Directions. | Cancer J | 2018 | https://conductscience.org/library/papers/30119081 | PubMed |
| 17 | 29556340 | The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes. | Theranostics | 2018 | https://conductscience.org/library/papers/29556340 | PubMed |
| 18 | 28697342 | Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. | Cancer Cell | 2017 | https://conductscience.org/library/papers/28697342 | PubMed |
| 19 | 28787701 | High expression of PCBP2 is associated with progression and poor prognosis in patients with glioblastoma. | Biomed Pharmacother | 2017 | https://conductscience.org/library/papers/28787701 | PubMed |
| 20 | 30132844 | Splicing factor poly(rC)-binding protein 1 is a novel and distinctive tumor suppressor. | J Cell Physiol | 2018 | https://conductscience.org/library/papers/30132844 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42569767 | Exploring the BICC1 Interactome in HEK293T Cells: Insights Into RNA-Mediated Protein Networks and Biomolecular Condensates. | FASEB Bioadv | 2026 | https://conductscience.org/library/papers/42569767 | PubMed |
| 42444932 | GNL3L-LMNB1 signaling axis promotes lung squamous cell carcinoma growth and ferroptosis resistance via NF-κB activation. | J Thorac Dis | 2026 | https://conductscience.org/library/papers/42444932 | PubMed |
| 40856423 | The GNL3L-MDM2 Interaction Drives Esophageal Squamous Cell Carcinoma Progression. | Cancer Med | 2025 | https://conductscience.org/library/papers/40856423 | PubMed |
| 39296333 | Expressions of the satellite repeat HSAT5 and transposable elements are implicated in disease progression and survival in glioma. | Turk J Biol | 2024 | https://conductscience.org/library/papers/39296333 | PubMed |
| 38169540 | Identification of basement membrane-related signatures for estimating prognosis, immune infiltration landscape and drug candidates in pancreatic adenocarcinoma. | J Cancer | 2024 | https://conductscience.org/library/papers/38169540 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34733320
GET https://conductscience.org/api/papers/v1/34733320/references?page=2